X
AZ forges surprise R&D deal with virus gene therapy biotech
https://pharmaphorum.com/top-pharmaceutical-companies/astrazeneca/az-steps-avv-field-medimmune-4dmt/
genetics
Explore the latest developments in ATMPs at Cell & Gene Therapy 2018
Cell & Gene Therapy 2018
Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency
A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle men’.
Oxford Nanopore’s tech reaches genome sequencing landmark
Oxford Nanopore one of many firms cutting time and cost of sequencing
Lundbeck trial investigates genetic causes of depression
New study with 23andMe and Milken Institute looks to determine causes of depression.
Hospital uses AI to embrace clinical genomics
AI can sift and analyse vast amounts of genomic data, enabling clinical scientists to better diagnose patients.
FDA approval for 23andMe’s direct-to-consumer genetics test
Service can now be marketed as test for Alheimer’s and Parkinson’s, among others.
Regeneron and GSK to sequence UK genetic data
Companies to sequence data from 500,000 volunteers from UK’s Biobank.
Fulcrum Therapeutics promises new drugs for rare disorders
Company launched following $55 million series A funding round.
